Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.117520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Ankita Shrivastava und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Stem Cell and Cancer Biology Program, Immunotherapy for Cancer and Inflammatory Disorders, Cancer Dormancy Inst…. Hauptthemen laut MEDLINE: Protein Biosynthesis, RNA, Messenger, Proto-Oncogene Proteins p21(ras), Mutation. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pharmacology, Stem Cell and Cancer Biology Program, Immunotherapy for Cancer and Inflammatory Disorders, Cancer Dormancy Institute, Data Science Institute, Albert Einstein College of Medicine, Mo…
- Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA.
- David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
- Department of Surgery and Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA.
- Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
- Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Förderung
- NICHD NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- NIH
- National Cancer Institute
- Albert Einstein College of Medicine, Yeshiva University
- Einstein-Montefiore CFAR
- Institute for Clinical and Translational Research, University of Wisconsin, Madison
Zitieren
APA
Shrivastava, A., Pederson, E. N., Nguyen, T. U., Chuen, J., Mohan, P., Pande, S., Toribio, A. R., Lecomte, N., Melchor, J., McAuliffe, J. C., Grandgenett, P. M., Rajasekhar, V. K., Nishikawa, K., Knörlein, A., David, Y., Willis, I. M., Iacobuzio-Donahue, C. A., Ouyang, Z., & Singh, K. (2026). Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117520
Vancouver
Shrivastava A, Pederson EN, Nguyen TU, Chuen J, Mohan P, Pande S, et al. Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117520
BibTeX
@article{Shrivastava2026,
author = {Shrivastava, Ankita and Pederson, Eric Nels and Nguyen, Trang Uyen and Chuen, Jacky and Mohan, Prathibha and Pande, Shivangi and Toribio, Ana Ruiz and Lecomte, Nicolas and Melchor, Jerry and McAuliffe, John C and Grandgenett, Paul M and Rajasekhar, Vinagolu K and Nishikawa, Kaila and Knörlein, Anna and David, Yael and Willis, Ian M and Iacobuzio-Donahue, Christine A and Ouyang, Zhengqing and Singh, Kamini},
title = {Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.117520}
}
EUVIMED